IMMUNITYBIO INC (IBRX) Institutional Ownership and Insiders Activity

IMMUNITYBIO INC (IBRX) is widely held by institutional investors, with 386 firms reporting positions valued at approximately $1.75B based on SEC Form 13F filings for the quarter ended June 30, 2026.

Blackrock, Inc. is the largest disclosed holder, reporting approximately $298.40M in IBRX holdings in its latest filing.

Recent insider activity includes 12 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.